Sign In
Buy CLOV
$3.65
-0.0800 (-2.14%)
At Close: Jun 03, 2026
Clover Health Investments, Corp. (CLOV) Q1 2026 Earnings Call Transcript
01:11pm, Thursday, 07'th May 2026
Clover Health Investments, Corp. (CLOV) Q1 2026 Earnings Call Transcript
Clover Health Q1 Earnings Meet Estimates, Sales Beat, Membership Rises
12:51pm, Thursday, 07'th May 2026
CLOV posts 62% revenue growth in Q1 as Medicare Advantage membership surges and AI-driven care initiatives boost profitability.
Clover Health Investments, Corp. (CLOV) Meets Q1 Earnings Estimates
07:35pm, Wednesday, 06'th May 2026
Clover Health Investments, Corp. (CLOV) came out with quarterly earnings of $0.07 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.05 per share a year ago.
Clover Health Reports First Quarter 2026 Results
04:05pm, Wednesday, 06'th May 2026
Business Highlights: Delivered positive GAAP Net Income in the first quarter of 2026, with strong performance across key metrics: Total revenues, Adjusted EBITDA, and Consolidated Gross Profit Market-
Butterfly Network, Inc. (BFLY) Reports Q1 Loss, Beats Revenue Estimates
08:41am, Thursday, 30'th Apr 2026
Butterfly Network, Inc. (BFLY) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.06 per share a year ago.
Here's Why You Should Retain Clover Stock in Your Portfolio for Now
11:41am, Thursday, 09'th Apr 2026
CLOV rides strong membership growth and an AI-driven care model, but rising costs and policy risks cloud the near-term outlook.
Clover Health to Report First Quarter 2026 Financial Results on May 6, 2026
04:05pm, Wednesday, 08'th Apr 2026
WILMINGTON, Del., April 08, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its
Clover Health Empowers Members to Take Charge of Their Health Data Through HealthEx Partnership
08:30am, Tuesday, 07'th Apr 2026
WILMINGTON, Del., April 07, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed
Clover Health Investments Target of Unusually Large Options Trading (NASDAQ:CLOV)
01:25am, Tuesday, 07'th Apr 2026
Clover Health Investments, Corp. (NASDAQ: CLOV - Get Free Report) saw unusually large options trading activity on Monday. Traders acquired 37,742 call options on the stock. This represents an increase
WILMINGTON, Del., April 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover” or the “Company”), a physician enablement company committed to bringing access to
Clover Health Investments, Corp. (NASDAQ:CLOV) Receives $2.90 Consensus PT from Analysts
03:32am, Monday, 30'th Mar 2026
Clover Health Investments, Corp. (NASDAQ: CLOV - Get Free Report) has received an average recommendation of "Hold" from the five ratings firms that are presently covering the firm, Marketbeat reports.
SAN FRANCISCO, March 19, 2026 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clove
Clover Health: Strong Growth, Improving Margins, And A Mispriced Stock
01:20am, Thursday, 19'th Mar 2026
Clover Health is positioned for a major turnaround, with operations and profitability metrics improving sharply despite market skepticism. CLOV projects 46% membership growth and 49% revenue growth fo
NOTICE: This is an updated version of a press release originally issued March 4, 2026 by Clover Health Investments, Corp. (Nasdaq: CLOV). Language has been updated to further refine the description of
Clover Health Enters Collaboration to Be Part of CMS Aligned Network
12:00pm, Thursday, 05'th Mar 2026
CLOV jumped 8% after partnering with Kno2 to become the first payer live on a CMS Aligned Network, enabling real-time patient access to clinical and claims data.
